[1]
A. K. . Duun-Henriksen, “Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosis”, AO, vol. 61, no. 8, pp. 931–938, Aug. 2022.